A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood
Status:
Completed
Trial end date:
2023-12-14
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to investigate the induction effect of multiple oral
doses of BI 1015550 on the pharmacokinetics of nintedanib or pirfenidone.